Project Grant 2126748
Award Date 12/1/21
Completion Date 11/30/22
Dollars Obligated $256K
Federal Agency
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
Ames, IA 50010, USA
Similar Awards
- The National Institute of Standards and Technology awarded Zymosense Inc. a $800,000 Cooperative Agreement under the Science, Technology, Business and/or Education Outreach federal grant program (CFDA 11.620) for the period of September 1, 2022 through August 31, 2024. Under this award, Zymosense will optimize its automated pipetting screening tool for assessing single-walled carbon nanotube dispersion and separation processes. In Phase I, the company demonstrated the feasibility of using the...
- This SBIR Phase I award from the National Science Foundation (NSF) under the Technology, Innovation, and Partnerships (TIP) program (CFDA 47.084) provides $275,000 to Caravel Bio, Inc. to develop a novel synthetic biology platform for high-throughput directed evolution of spore-displayed enzymes. The project aims to create customizable enzyme solutions for industrial biocatalyst applications by improving key properties like enzyme activity, stability, and loading density. The technology uses a...
- This two-year, $200,000 Project Grant from the National Science Foundation's Division of Chemical, Bioengineering, Environmental, and Transport Systems will fund research at the Long Beach Research Foundation to develop multi-activity proteins for improved carbohydrate deconstruction. Specifically, the Foundation will produce and test 85 engineered multi-activity proteins containing two catalytic domains each. These proteins aim to increase biomass conversion for alternative fuels and...
- Zelosdx, Inc. received a $255,763 Project Grant award from the National Science Foundation Division of Industrial Innovation under the Engineering federal grant program (CFDA 47.041). The grant funding supports research titled "Phagocytic Cells in Peripheral Blood as a Novel Diagnostic Tool for Brain Health" from August 1, 2021 through July 31, 2022. The Engineering program seeks to improve quality of life and economic strength by fostering innovation and excellence in engineering...
- This National Science Foundation (NSF) Technology, Innovation, and Partnerships (CFDA 47.084) Project Grant award of $274,918 to Cascade Biocatalysts Inc. will fund research and development to demonstrate the commercial feasibility and scalability of a patent-pending approach for stabilizing enzymes through engineered polymer-enzyme interactions. The goal is to enable environmentally sustainable, low-carbon chemical manufacturing processes that utilize enzymes as catalysts, which can decrease...
- This National Science Foundation (NSF) Project Grant award for $380,074, awarded on September 1, 2024, aims to develop a platform for instrument-free, easy-to-interpret quantitative analysis of molecular biomarkers. The project will produce a general methodology adaptable to a range of molecular targets, including potential new agents. The key products to be delivered include: A "yes/no" output for quantitative measurement, enabled through stoichiometry and negative cooperativity-based...
- Synvivia Inc. received a $255,910 Project Grant award from the National Science Foundation Division of Industrial Innovation on December 1, 2021 to develop a novel biosafety platform using synthetic auxotrophs. The one-year project, which will be completed by November 30, 2022, aims to advance the NSF Directorate for Engineering's goals of improving quality of life and economic strength through innovative engineering research. Specifically, the grant will support Synvivia's work to create a...
- Exciplex, Inc. received a $256,000 Small Business Innovation Research Phase I Project Grant from the National Science Foundation Division of Industrial Innovation under the Engineering federal grant program (CFDA 47.041) to develop advanced mycotoxin detection with novel photochemical diagnostics. The one-year project period runs from December 2021 through November 2022. The NSF Directorate for Engineering seeks to improve quality of life and economic strength through fostering innovation,...
- Biomesense Inc. received a $255,658 National Science Foundation SBIR Phase I Project Grant to develop a novel biosensor to accelerate investigations of COVID-19 and the gut microbiome. Funded under the NSF Engineering program (CFDA 47.041), this six-month award beginning January 15, 2021 supports the company's work to design a portable, low-cost biosensor device capable of rapidly detecting SARS-CoV-2 and analyzing gut microbiome composition directly from patient samples. The NSF Directorate for...
- This National Science Foundation (NSF) Technology, Innovation, and Partnerships (CFDA 47.084) program award provides $274,990 to Dencoda LLC to develop a novel DNA-based kinase assay platform. The key products to be delivered are: A highly sensitive, specific, and multiplexed kinase activity assay that can be used as a research tool to discover new therapeutic targets or as a clinical diagnostic test for diseases involving kinase dysregulation, such as cancers, diabetes, and Alzheimer's disease....